Cutaneous lesion induced by a subcutaneous administration of bortezomib.
Department of Infectious Diseases, St John Hospital and Medical Center, Detroit, MI 48236, USA.
Karam M
KM
Obeid
Richard
R
Ferrara
Mamta
M
Sharma
D000368:Aged; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D001897:Boronic Acids / Q000008:administration & dosage / Q000009:adverse effects*; D000069286:Bortezomib; D004305:Dose-Response Relationship, Drug; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D006801:Humans; D055104:Infusions, Subcutaneous; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy / Q000473:pathology*; D011719:Pyrazines / Q000008:administration & dosage / Q000009:adverse effects*
D000970:Antineoplastic Agents; D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib